RxDoctor Payments Data

Isaac Yepes

Chicago, ILNPI 1639662695

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (37.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Abbott at 47.9% of the total. 2025 is the largest year on record at $13,095, more than ten times the $286 reported in 2019.

$33,174in general payments, 2019–2025

Across 188 payments — averaging $176.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$16K
  • Medtronic$5K
  • Biotronik Inc.$5K
  • Boston Scientific$4K
  • Philips North America LLC$1K
  • Biosense Webster, Inc.$232
  • plus $693 from 8 others

What the payments were for

  • Grants$12,50038%
  • Travel & lodging$9,98830%
  • Food & beverage$9,51729%
  • Education$1,1694%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$14,963

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →